ESSENTIAL THROMBOCYTOSIS

Clinical trials for ESSENTIAL THROMBOCYTOSIS explained in plain language.

Never miss a new study

Get alerted when new ESSENTIAL THROMBOCYTOSIS trials appear

Sign up with your email to follow new studies for ESSENTIAL THROMBOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New pill aims to shrink spleens and ease symptoms in tough blood cancers

Disease control Completed

This study tested an experimental pill called pelabresib, both alone and combined with an existing drug (ruxolitinib), for people with myelofibrosis and other blood cancers. The main goals were to find a safe dose and see if the treatment could reduce spleen size, ease symptoms l…

Matched conditions: ESSENTIAL THROMBOCYTOSIS

Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control

Last updated Apr 03, 2026 14:43 UTC

ESSENTIAL THROMBOCYTOSIS

Get alerted when new ESSENTIAL THROMBOCYTOSIS trials appear

New pill aims to shrink spleens and ease symptoms in tough blood cancers